IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CRGOW

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022
Cash & Equivalents13.3519.9810.1221.0020.179.296.49
Total Current Assets36.1143.8246.1055.4559.7268.8912.97
Goodwill14.8115.3415.0415.6315.6315.6315.63
Total Non-current Assets26.5927.8127.6826.7127.9728.3228.84
Total Assets62.7071.6473.7882.1587.6997.2141.81
Total Current Liabilities16.7520.3717.3115.9812.1813.9917.08
Total Non-current Liabilities3.022.501.581.873.465.433.07
Total Liabilities*19.7722.8718.8917.8515.6419.4220.15
Retained Earnings(224.19)(215.45)(206.67)(194.11)(184.18)(173.70)(118.71)
Total Stockholder Equity42.9248.7754.8964.3172.0477.7821.66
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023
Total Revenue14.3811.019.92
Cost of Revenue*4.753.994.19
Gross Profit9.637.025.73
Research & Development5.914.906.01
Selling, General & Admin5.385.346.08
Total Operating Expenses18.8317.0769.59
Operating Income(9.19)(10.05)(63.87)
Pretax Income(8.68)(9.95)(54.99)
Tax Provision0.09(0.02)0.00
Net Income(8.78)(9.93)(55.00)
Basic EPS(0.18)(0.21)(1.33)
Diluted EPS(0.18)(0.21)(1.33)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023
Operating Cash Flow(2.53)(4.50)(18.81)
Investing Cash Flow11.945.51(51.47)
Financing Cash Flow0.19(0.11)73.27
← Scroll for more columns →